• LAST PRICE
    16.0850
  • TODAY'S CHANGE (%)
    Trending Up0.2750 (1.7394%)
  • Bid / Lots
    15.8800/ 2
  • Ask / Lots
    16.0600/ 1
  • Open / Previous Close
    15.7600 / 15.8100
  • Day Range
    Low 15.3000
    High 16.0850
  • 52 Week Range
    Low 12.2850
    High 37.1100
  • Volume
    50,979
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 15.81
TimeVolumeVERA
09:32 ET13615.76
09:35 ET10015.72
10:11 ET10015.79
10:45 ET10015.71
10:47 ET10015.71
10:51 ET50015.89
11:03 ET10015.83
11:12 ET10015.875
11:41 ET10015.78
11:48 ET10015.71
12:03 ET10015.64
12:21 ET10015.62
12:42 ET20015.61
12:44 ET30015.6152
01:02 ET70015.4
01:09 ET40015.55
01:22 ET10015.41
01:27 ET30015.485
01:40 ET10015.43
01:44 ET10015.57
01:56 ET10015.48
01:58 ET10015.34
02:12 ET10015.35
02:25 ET1709515.385
02:27 ET1827415.3
02:30 ET15015.47
02:32 ET50015.465
02:34 ET20115.49
02:38 ET35015.58
02:39 ET10015.72
02:41 ET40015.8
02:43 ET70015.91
02:45 ET10015.92
02:48 ET40015.955
02:50 ET10015.865
02:52 ET10015.94
02:54 ET20015.955
02:56 ET30015.95
02:57 ET10016.085
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVERA
Vera Therapeutics Inc
437.3M
-5.4x
---
United StatesPMVP
PMV Pharmaceuticals Inc
437.5M
-6.0x
---
United StatesVIGL
Vigil Neuroscience Inc
435.9M
-5.8x
---
United StatesBTAI
BioXcel Therapeutics Inc
439.1M
-3.1x
---
United StatesTRDA
Entrada Therapeutics Inc
442.5M
-2.7x
---
United StatesALT
Altimmune Inc
444.9M
-5.0x
---
As of 2022-11-29

Company Information

Vera Therapeutics, Inc. is a late-stage biotechnology company. The Company is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its lead product candidate, atacicept, a self-administered fusion protein that blocks both B lymphocyte stimulator (BLyS) and a proliferation inducing ligand (APRIL), which stimulates B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Atacicept is being developed for the treatment of immunoglobulin A nephropathy (IgAN), a rare autoimmune disease that can lead to dialysis, kidney transplant, serious disease, and early death. It is also developing MAU868, a monoclonal antibody that neutralizes infection with BK Virus. The Company is also planning to initiate a Phase III clinical trial of atacicept as a potential treatment for patients with LN, a severe renal manifestation of Systemic Lupus Erythematosus (SLE).

Contact Information

Headquarters
8000 Marina Boulevard Suite 120, 3Rd FloorBRISBANE, CA, United States 94005
Phone
650-770-0077
Fax
302-655-5049

Executives

Independent Chairperson of the Board of Directors
Kurt Von Emster
President, Chief Executive Officer, Founder, Director
Marshall Fordyce
Chief Financial Officer
Sean Grant
Senior Vice President - Finance, Chief Accounting Officer
Joseph Young
Senior Vice President - Development Operations
Tom Doan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$437.3M
Revenue (TTM)
$0.00
Shares Outstanding
27.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.95
Book Value
$3.27
P/E Ratio
-5.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.